Pleiotropic Functions for Transcription Factor Zscan10 by Kraus, P. et al.
Pleiotropic Functions for Transcription Factor Zscan10
Petra Kraus1,2, Sivakamasundari V1, Hong Bing Yu1, Xing Xing1, Siew Lan Lim1, Thure Adler3,4, Juan
Antonio Aguilar Pimentel3,4,12, Lore Becker3,4, Alexander Bohla3,13, Lillian Garrett3,5, Wolfgang Hans3,4,
Sabine M. Ho¨lter3,5, Eva Janas3,6, Kristin Moreth3,4, Cornelia Prehn3,4, Oliver Puk3,5, Birgit Rathkolb3,7,
Jan Rozman3,4, Jerzy Adamski3,4, Raffi Bekeredjian3,8, Dirk H. Busch3,9, Jochen Graw3,5,
Martin Klingenspor3,10, Thomas Klopstock3,11, Frauke Neff3,6, Markus Ollert3,12, Tobias Stoeger3,13, Ali
O¨nder Yildrim3,13, Oliver Eickelberg3,13, Eckhard Wolf3,7, Wolfgang Wurst3,5,16,17,18,19, Helmut Fuchs3,4,
Vale´rie Gailus-Durner3,4, Martin Hrabeˇ de Angelis3,4,14,15, Thomas Lufkin1,2, Lawrence W. Stanton1*
1 Stem Cell and Developmental Biology, Genome Institute of Singapore, Singapore, Singapore, 2Department of Biology, Clarkson University, Potsdam, New York, United
States of America, 3German Mouse Clinic, Helmholtz Zentrum Mu¨nchen, German Research Center for Environmental Health, Neuherberg, Germany, 4 Institute of
Experimental Genetics, Helmholtz Zentrum Mu¨nchen, German Research Center for Environmental Health, Neuherberg, Germany, 5 Institute of Developmental Genetics,
Helmholtz Zentrum Mu¨nchen, German Research Center for Environmental Health, Neuherberg, Germany, 6 Institute of Pathology, Helmholtz Zentrum Mu¨nchen, German
Research Center for Environmental Health, Neuherberg, Germany, 7Chair for Molecular Animal Breeding and Biotechnology, Gene Center, Ludwig-Maximilians-Universita¨t
Mu¨nchen, Munich, Germany, 8Department of Medicine III, Division of Cardiology, University of Heidelberg, Heidelberg, Germany, 9 Institute of Medical Microbiology,
Immunology, and Hygiene, Technische Universita¨t Mu¨nchen, Munich, Germany, 10Molecular Nutritional Medicine, Else Kro¨ner-Fresenius Center, Technische Universita¨t
Mu¨nchen, Freising-Weihenstephan, Germany, 11Department of Neurology, Friedrich-Baur-Institut, Ludwig-Maximilians-Universita¨t Mu¨nchen, Munich, Germany,
12 Klinikum rechts der Isar der Technischen Universita¨t Mu¨nchen, Klinik und Poliklinik fu¨r Dermatologie und Allergologie am Biederstein, Munich, Germany,
13Comprehensive Pneumology Center, Institute of Lung Biology and Disease, Helmholtz Zentrum Mu¨nchen, German Research Center for Environmental Health,
Neuherberg, Germany, 14Chair of Experimental Genetics, Center of Life and Food Sciences Weihenstephan, Technische Universita¨t Mu¨nchen, Freising-Weihenstephan,
Germany, 15Member of German Center for Diabetes Research, Neuherberg, Germany, 16Chair of Developmental Biology, Technische Universita¨t Mu¨nchen, Freising-
Weihenstephan, Germany, 17Max Planck Institute of Psychiatry, Munich, Germany, 18Deutsches Institut fu¨r Neurodegenerative Erkrankungen Site Munich, Munich,
Germany, 19Munich Cluster for Systems Neurology, Munich, Germany
Abstract
The transcription factor Zscan10 had been attributed a role as a pluripotency factor in embryonic stem cells based on its
interaction with Oct4 and Sox2 in in vitro assays. Here we suggest a potential role of Zscan10 in controlling progenitor cell
populations in vivo. Mice homozygous for a Zscan10 mutation exhibit reduced weight, mild hypoplasia in the spleen, heart
and long bones and phenocopy an eye malformation previously described for Sox2 hypomorphs. Phenotypic abnormalities
are supported by the nature of Zscan10 expression in midgestation embryos and adults suggesting a role for Zscan10 in
either maintaining progenitor cell subpopulation or impacting on fate choice decisions thereof.
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Introduction
Zscan10 (previously known as Zfp206) is a 14 zinc finger
transcription factor (ZF-TF) of the C2H2 ZF-TF subfamily with a
N-terminal SCAN domain [1,2] located on mouse chromosome
17. It was discovered during an array screen in mouse [3] and a
transcriptome characterization of human embryonic stem cells [4].
Zscan10 has at least six known alternative splice forms, is
expressed in undifferentiated human and mouse embryonic stem
cells (ESC) [3,4], the inner cell mass (ICM) of blastocysts [5] and
down regulated upon differentiation [3,6]. Zscan10 is considered
to maintain ESC pluripotency by interacting with the established
pluripotency markers Sox2 and Oct4 [7]. More than 3000 binding
sites were identified for Zscan10 in a genome wide screen of which
183 were commonly targeted by this trio [1]; suggesting a direct or
indirect role of Zscan10 in controlling many developmental
processes by activating or suppressing other transcription factors.
Post-implantation expression of the Zscan10 isoform 2 has been
reported by whole mount RNA in situ hybridization (WISH) in
the ecto- and mesoderm but not the endoderm of embryonic day
7.5 (E7.5) mouse embryos. Expression remained in the otic vesicle,
the branchial arches and the hindgut between E9.0–9.5 and
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became barely detectable at E10.5 [3], while WISH using a probe
based on the last exon of Zscan10 indicated expression in the
ectoderm and mesoderm but not endoderm of E7.5 embryos and
low level expression in all germ layers from E9.5 to E12.5.
Northern blot analysis performed with a 60 bp oligonucleotide
located in the last exon of Zscan10 revealed strongest expression in
embryos at E4.5–E5.5 and E10.5–E13.5, while in the adult
expression was limited to the testis [6]. Subsequently qPCR
analysis indicated low level expression in brain and liver. Array
data from Zhang et al. indicated upregulation of Zscan10
expression in E9.5 embryos as well as lymph nodes, the spinal
cord, testis and epididymis as well as femur and calvarial bones
[3]. While the last exon is present in the most abundant isoforms of
Zscan10, only exon 4 is shared amongst all six known alternative
splice variants [3].
During post-fertilization pre-implantation stages in mouse, a
totipotent zygote develops into a pluripotent blastocyst by E3.5
with only the cells of the ICM retaining the pluripotent state.
Pluripotent ESC can be derived from the ICM of blastocysts [8,9].
Upon injection of pluripotent ESC into 2C–8C stage pre-
implantation embryos [10] or blastocysts [11] chimeric organisms
can be generated. The degree of chimerism is determined by the
degree of pluripotency of any given injected ESC and its ability to
outcompete cells of the host organism to achieve contribution to
the chimeric organism and from an evolutionary point of view,
most importantly its germ line [10]. Upon undergoing differen-
tiation, a pluripotent stem cell can divide into a terminally
differentiated cell or become a more specialized progenitor cell
with multi- or unipotent potential [12].
Here we propose a possible role for Zscan10 in the maintenance
of multipotent progenitor cells based on the pleiotropic phenotype
revealed by an exhaustive screen of Zscan10 homozygous mutant
mice derived from clone #285B6 (CMMR) of a gene trap located
59 to the ATG start codon of Zscan10, which should render null
all known protein isoforms of Zscan10, yet allow residual 39 RNA
expression to persist. Typically affected organs did retain residual
Zscan10 RNA expression in distinct cells during midgestation
development and even in the adult and were generally determined
to be hypoplastic in the Zscan10 homozygous mutants.
Materials and Methods
Generation of homozygous mutant Zscan10 gene trap
mice
Zscan10 mutant mice were generated by injecting the R1
mouse ESC clone #285B6, obtained from the Canadian Mouse
Mutant Repository (CMMR) (Toronto, Canada), into C57BL/6
2C–8C stage embryos as described in Kraus et al. [10], achieving
germline transmission and generating a stable line that was
backcrossed for more than three generations onto a C57BL/6
background. According to CMMR clone #285B6 resulted from a
gene trap insertion of the pUPA vector prior to the translation
start codon of Zscan10 as confirmed by 39RACE performed by
CMMR. For a schematic of the gene trap allele see Figure S1. As
recommended by CMMR, heterozygous mice were mated with
the ZP3-Cre deleter strain [13] to remove a floxed IRESx3
sequence inherent to the pUPA gene trap vector used by CMMR.
Genotyping was performed by PCR using the AccuPrime Taq
DNA polymerase system on 50 ng of genomic DNA isolated from
tail tips for 30 cycles at 94uC for 30 s/58uC for 30 s/68uC for 60 s
with primers for the mutant (285B6-mut-F: 59-CGATGATCTC-
GTCGTGACCC-39/ 285B6-mut-R: 59-CGGGTCAAATTAC-
GAGGTGCT-39) and wild type allele (285B6-wt-F: 59-CTGGC-
AAGTCCTCACCTAGAAATT-39/ 285B6-wt-R: 59-CTGCAG-
CAGATGCTCGTGAGTT-39), generating a 300 bp wild type
allele and a 1100 bp and 500 bp mutant allele before and after
Cre recombination, respectively.
Ethics statement and animal housing
All animal procedures were performed according to the
Singapore A*STAR Biopolis Biological Resource Center (BRC)
Institutional Animal Care and Use Committee (IACUC) guide-
lines which are set by the National Advisory Committee for
Laboratory Animal Research (NACLAR). The IACUC protocols
employed were reviewed and approved by the aforementioned
committee before any animal procedures were undertaken for this
study described here (IACUC Protocol No: 110689 and 110648).
The mouse strains used in this study were housed, maintained and
provided by the A*STAR Biopolis Biological Resource Center
(BRC) (Singapore) & the German Mouse Clinic (GMC) (Neuher-
berg, Germany) and maintained in IVC cages according to BRC
and GMC housing conditions and Singaporean and German laws.
All tests performed at the GMC and described here were approved
for the ethical treatment of animals by the responsible authority of
the Regierung von Oberbayern (Government of Upper Bavaria).
The lines described here will be made available to the research
community upon acceptance of the manuscript.
RNA in situ hybridization and Western blot
RNA in situ hybridization on 10 um paraffin sections (SISH)
was carried out, essentially as described [14], with the exception
that the probes were generated by PCR amplification of wild type
mouse cDNA derived from embryonic E12.5 and R1 ESC, as
described [15,16]. Several Zscan10 probes have been used for
SISH, emphasized here is the 270 bp probe template that spans
exons 3 to 5 of the Zscan10 cDNA, precisely from base pair
position 667 to 937 of the reference sequence NM_001033425 and
the 1355 bp probe template spanning base positions 433 to 1788.
PCR was carried out following standard PCR procedures using
GoTaq (Promega) at 1.0 mM MgCl2 on a Nexus Eppendorf
thermocycler with a 40 s annealing step at 65uC and 2.0 mM
MgCl2 at 60uC, respectively, for 35 cycles with primers including
the sequence for the T3 and T7 RNA polymerase promoters, to
generate a DIG labeled sense and antisense probe, respectively,







GGGCTAGTTGCTCGCTTTGTCGGAA-39. Likewise a ,1 kb
probe for Sox2 was generated using the primers: T7_Sox2_S: 59-
GCGCGCGTAATACGACTCACTATAGGGCTTTGTCCGA-
GACCGAGAAGC-39, T3_Sox2_AS: 59- CGCGCGCAAT-
TAACCCTCACTAAAGGGGAAGCGCCTAACGTACCACT-
39. The ORFHes5 probe was a generous gift from Urban Lendahl.
The probe template for the pUPA reporter gene EGFP was
amplified using the primers EGFP_T7: 59-CGCGCGCAAT-
TAACCCTCACTAAAGGGCCTACGGCGTGCAGTGCTTC-
AGC-39 and EGFP_T3: 5:-CGCGCGGTAATACGACTCAC-
TATAGGGCCGGCGAGCTGCACGCTGCCGTCC-39.
Western blot was essentially performed as described [6] with a
Zscan10 specific antibody at 1:3000 and aRB-HRP 1:10000 as
control (see Figure S5). For comparison wild type (+/+),
heterozygous (+/2) and homozygous (2/2) ESC were derived
from blastocysts of Zscan10+/2 x Zscan10+/2 matings. The
homozygous (2/2) line L2 was maintained on gelatinized plates
Zscan10 Pleiotropic Functions
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in the absence (GEL) or presence (MEF) of mouse embryonic
fibroblast feeder cells all maintained in ES medium+LIF.
Phenotype screen at GMC
The GMC screen (www.mouseclinic.de) comprises exhaustive,
standardized phenotyping in the realms of dysmorphology,
cardiovascular health, energy metabolism, clinical chemistry,
eye, lung function, molecular phenotyping, behavior, neurology,
nociception, immunology, steroid metabolism and pathology.
Phenotypic screens at the GMC were performed according to
standardized methods [17,18,19]. A cohort of each 15 male and
15 female wild type and homozygous mutant adult mice derived
from timed heterozygous x heterozygous matings, all born within
one week, was subjected to the GMC phenotyping program
between the age of 9 to 18 weeks. If not stated otherwise, data
generated by the GMC was analyzed using R. Tests for genotype
effects were made by using t-test, Wilcoxon rank sum test, linear
models, or ANOVA depending on the assumed distribution of the
parameter and the questions addressed to the data. A p-value ,
0.05 has been used as level of significance; a correction for multiple
testing has not been performed.
Dysmorphology and skeletal analysis
Macroscopic examination to identify any morphological
abnormalities was performed according to GMC standard
operating procedures (SOP). Growth weight and body size was
determined. Mice were subjected to morphological observation
and hearing abilities were analyzed following the protocol
described previously [20]. X-ray imaging of animals was
performed in a Faxitron MX-20 Cabinet X-ray system equipped
with a DC12 digital camera (Faxitron X-ray, Illinois, USA). The
system is run with settings: Voltage 26 kV and automatic exposure
control. Bone mineral density was analyzed using pDEXA Sabre
X-ray Bone Densiometer (Norland Medical Systems. Inc.,
Basingstoke, Hamshire, UK) scan speed 20 mm/s, resolution
0.5 mm61.0 mm, Histogram Averaging Width setting 0.020 g/
cm2.
Eye analysis and pathology
Morphological alterations of the eye such as anterior segment
abnormalities were assessed by Scheimpflug imaging, posterior
segment abnormalities, eye fundus and retina were analyzed by
optical coherence tomography. The axial eye length was measured
by laser interference biometry [21] and visual properties were
studied in tests involving a virtual drum [22]. For microscopic
histological analysis all organs (skin, heart, muscle, lung, brain,
cerebellum, thymus, spleen, cervical lymph nodes, thyroid,
parathyroid, adrenal gland, stomach, intestine, liver, pancreas,
kidney, reproductive organs and urinary bladder) were fixed in 4%
buffered formalin, embedded in paraffin, sectioned at a thickness
of 2 um and subjected to hematoxylin and eosin staining as
described before [19].
Neurological examination and behavioral testing
For the assessment of basic neurological functions, muscle
function as well as motor coordination and balance, a modified
SHIRPA protocol was applied and grip strength and Rota rod
performance were measured as described previously [19].
Behavioral screens to analyze locomotion and anxiety-related
behavior as well as sensory motor gaiting were done by open field
(OFT), acoustic startle and prepulse inhibition (PPI) testing as
described before [23,24].
Clinical chemistry, hematology and immunology
assessment
Blood samples were collected at 16 weeks of age by retrobulbar
puncture under isoflurane anesthesia. Determination of clinical-
chemical parameters in heparinized plasma samples was done
using an AU480 (Beckman-Coulter, Krefeld, Germany) and
reagents kits provided by Beckman-Coulter, as described previ-
ously [25]. Hematological analyses were performed with an ABC-
animal blood counter (Scil animal care company, Viernheim,
Germany) on whole blood samples collected in EDTA-coated
tubes. Glucose tolerance was tested by an intraperitoneal glucose
tolerance test (IpGTT) performed after overnight food withdrawal
using the Accucheck Aviva glucometer (Roche, Penzberg,
Germany) for glucose blood level determination, as described
previously [26]. Analysis of peripheral blood samples was done by
flow cytometry and Bioplex multiplex bead array [17,19].
Heart and lung function screen
Awake echo was used for the assessment of cardio-vascular
functions [26] while assessment of lung volumes and mechanics
was performed by Buxco FinePointeRC and Forced Maneuvers
systems as described previously [19].
Energy and steroid metabolism
Measurement of body mass, body temperature, locomotor
activity, O2 consumption, CO2 production, respiratory exchange
ratio and body composition was assessed by indirect calorimetry
and qNMR (MiniSpec LF50, Bruker Optics, Ettlingen/Germany).
The steroid hormones testosterone, corticosterone and androsten-
dione were analyzed out of 50 ul plasma by liquid chromatogra-
phy tandem mass spectrometry (LC-MS/MS) according to
Rathkolb et al [25].
Results
Underrepresentation of homozygous Zscan10 mutant
females at weaning age
While homozygous Zscan10 mutants were viable and fertile,
genotyping offspring (n = 153) from heterozygous x heterozygous
matings at weaning age (postnatal day 21) revealed a slight
deviation from the expected Mendelian ratio, with the number of
homozygous females being 30% lower than that of wild type
females (see Table S1). Notably, homozygous mice were fertile and
could be maintained as homozygous x homozygous, yet their
breeding performance generally dropped after a few litters and the
offspring appeared increasingly runted (data not shown). There-
fore, heterozygous x heterozygous matings were preferred to
maintain the Zscan10 mutant mouse line. Zscan10 is known to
have several alternative splice forms (see Figure S1). While the
integration of the gene trap allele will not prevent residual RNA
transcripts from being generated, it is very unlikely that any of the
Zscan10 protein isoforms are produced (see Figure S5).
Decreased body weight, bone mass and bone mineral
content in Zscan10 homozygous mutant females
The body mass of the female mutant Zscan10 cohort was
slightly, but significantly, (p = 0.042) reduced (see Figure 1A-D); in
male mutant mice a reduction was observed but did not reach a
significant value. The relationship between body fat content and
lean mass was not different between mutant and wild type mice,
therefore no clear shift in body composition could be detected (see
Figure 1D,E,G). In the dual-energy X-ray absorptiometry (DXA)
a significantly decreased bone mineral content (BMC) and bone
Zscan10 Pleiotropic Functions
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Figure 1. Zscan10 mutant females show decreased body weight. (A) Body mass time curve of mutant and control cohorts, n = 60. (B) Body
weight boxplot with strip chart, split by sex and genotype. Bodyweight is significantly reduced in female mutant mice (p = 0.042). (C) Bodyweight
means, standard deviation and p-values calculated by a linear model (D) Body composition analysis by NMR: means, standard deviation and p-values
of a linear model. (E) DXA analysis: Group means, standard derivation and ANOVA (Tukey multiple comparisons of means). (F) Tibia length box plot
with strip chart. Split by sex and genotype. Tibia length is significantly reduced in female mutant mice. (G) Indirect calorimetry: Average body weight
at indirect calorimetry boxplot with strip chart, split by sex and genotype. Points are individual animals; circles represent females (f); diamonds
represent males (m) of Zscan10 homozygous mutants (mut) and wild type littermates (con). Line within the boxplot represents median. Box
represents the 25% and 75% quartile. Asterix represents the mean. Circled points: Values outside the upper whisker (min(max(x), 75% quantile +
1.5*IQR) and outside the lower whisker (max(min(x), 25% quantile+1.5*IQR) = outliers. IQR = interquartile range (75% quantile–25% quantile).
doi:10.1371/journal.pone.0104568.g001
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content was observed in female mutants (see Figure 1E). The tibia
length was significantly reduced in female mice (see Figure 1F).
Abnormalities of Zscan10 homozygous mutant mice
revealed by immunological, hematological and clinical
chemistry screening
The clinical-chemical and hematological screen detected several
changes indicating effects of the Zscan10 mutation on renal
function as well as platelet number and morphology. The glucose
metabolism and tolerance was unaffected in an intraperitoneal
glucose tolerance test (IpGTT) (data not shown). Zscan10 mutant
mice presented with moderately decreased chloride and mildly
reduced albumin concentration in plasma, while creatinine and
urea levels were increased in these mice compared to controls (see
Figure 2A). Plasma lactate dehydrogenase (LDH) activity gener-
ally present in body tissues, such as blood cells and heart muscle, is
released upon tissue damage, and therefore a valuable indicator
thereof. LDH activity was significantly increased in female mutant
mice, while it tended to be lower in mutant males (see Figure 2B).
Calcium was decreased in male mutants compared to male
controls, while no effect was observed in the female cohorts (see
Figure 2C). Alkaline phosphatase (ALP) activity was not increased
in mutant animals (see Figure 2C). No significant effect on red
blood cell count or morphology was observed, platelet counts were
significantly decreased and the mean platelet volume (MPV) was
increased in Zscan10 mutants (see Figure 2D,E,F). A higher
frequency of T-cells in mutants went together with a lower CD4+/
CD8+ ratio. The frequency of CD25-expressing cells within the
CD4+ T-cell cluster, the frequency of CD11b expressing cells
within the NK-cell cluster, and the frequency of MHC class II-
expressing cells within the B-cell cluster was higher in mutants,
also higher levels of IgG1, IgG2b and an increased ratio of IgG1/
IgG2b was detected in mutants. Plasma IgE levels were unaffected
(see Figure S2). Concentrations of corticosterone, androstendione
and testosterone in the plasma of Zscan10 mutant and control
mice aged 16 weeks revealed a statistically significant decrease in
corticosterone levels in male mutants (see Figure 2G).
Neurological and behavioral abnormalities in Zscan10
homozygous mutant mice
Female mutant mice showed increased locomotor activity (total
distance travelled) and increased locomotor speed (p,0.05) in the
open field and entered the center more frequently while male
mutant mice showed the opposite effect (interactions genotype x
sex: p,0.05) (see Figure 3A,B,C and Figure S3). Male mutant
mice also exhibited increased PPI and female mutants exhibited an
increase in acoustic startle reactivity at higher sound pressure
levels (data not shown).
SHIRPA is a standardized observation protocol for assessment
of genetically modified mice. During this test increased occurrence
of urination was detected for two thirds of the mutant cohort,
compared to only one third of the wild type mice (p = 0.00921,
n = 30). Measuring grip strength for the evaluation of muscle
function revealed reduced force in 2- and 4-paw measurement.
However, the mutant mice were also significantly lighter (see
Figure 1A,B,C) and including body mass as a confounding factor
into statistical analysis confirmed body mass as the main effect on
grip strength. During Rota rod analysis, mutants fell off the Rota
rod more often while controls rotated passively, a behavior also
rated as a failure thus leading to manual timer stop. This
difference in the strategy on the rod, however, had no influence on
mean latencies (data not shown). Other parameters covering
overall appearance, movement and reflexes were without any
significance.
Reduced eye size in Zscan10 homozygous mutant mice
Significantly reduced eye sizes in both male and female Zscan10
mutants were detected, present already at midgestation (see
Figure 4A-D and data not shown). Laser interference biometry
revealed significantly reduced axial eye lengths in mutants of both
sexes (P,0.0001) (see Figure 4E). Borderline significant increased
opacification of left and right lenses of male and female mutants,
respectively, was observed. Scheimpflug imaging indicated signif-
icantly increased mean lens density between controls and mutants,
yet with a surprising unilateral restriction to left eyes in mutant
males (p = 0.002) and right eyes in mutant females (p = 0.016) (see
Figure 4F,G). Optical coherence tomography demonstrated a
normally developed fundus with no significant alteration in the
number of main blood vessels or retinal thickness in the posterior
part of the eye. While male mutants showed regular responses to
the moving stripe pattern in the virtual drum vision test, female
mutants showed a reduced response with a borderline significance
(p = 0.034) (see Figure 4H).
Further phenotypic findings in Zscan10 homozygous
mutant mice
Awake echocardiography of Zscan10 homozygous mutants and
respective controls revealed increased systolic left ventricular
internal dimensions (LVIDs) and a decreased respiration rate
mainly in male mutants. Further, Zscan10 mutants showed a
decreased heart rate when compared with control mice (data not
shown). Thus, only mild genotype-related differences without
relevance for the cardiovascular system were found. Lung function
screening showed a slight yet significant but functionally rather
irrelevant decreased dynamic compliance (p = 0.026) and tidal
volume (p = 0.004) (data not shown). Body temperature showed a
tendency to be slightly lower in male mutants (data not shown).
In homozygous male mutant mice an increase in liver weight
normalized to body weight was determined (see Figure 5A). A
slightly reduced absolute and normalized spleen and heart weight
in particular in female mutants was observed (see Figure 5B-E,
and Figure S4), yet no morphological changes of internal organs
were detected during histological analysis.
Zscan10 expression in midgestation embryos supports
phenotypic findings
Phenotypically affected organs in the screen performed by
GMC led us to revisit embryonic and adult Zscan10 expression.
Since expression pattern analysis was previously established by
WISH [3,6], a technique prone to probe entrapment, lack of
proper penetration of the probe and other obstacles, SISH was
performed. A 270 bp probe essentially spanning exons 3 to 5 and a
1.35 kb probe essentially covering exon 2 to the proximal part of
exon 6 was used and compared with an EGFP probe reflecting the
pUPA reporter gene expression (see Figures S1 and S6). As
determined by repeat masker (www.repeatmasker.org), the
Zscan10 probes were free of repetitive elements and specific to
Zscan10. In several independent experiments (n = 6) we observed
a punctate expression pattern (a positive cell surrounded by
numerous non-expressing cells) in E12.5 and E15.5 embryos,
namely in kidneys, heart, liver, muscle and developing bones of the
forelimb, but in a similar matter in neural tissue like the neural
tube, the brain and in dorsal root ganglia and sensory organs like
the eye (see Figure 6B,D-K). Strongest expression of such kind was
located in the linings of stomach and gut (see Figure 6D,E,G). This
Zscan10 Pleiotropic Functions
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punctate expression pattern for Zscan10 was still observed in the
organs of adult mice as shown for sections of the heart, kidney and
eye (see Figure 7). Expression of the pUPA reporter gene EGFP
coincided with Zscan10 expression (see Figure S6M-X). The
bHLH transcription factor Hes5 [27], a downstream effector in
the Notch pathway [28] involved in eye, especially retinal
development [29], appeared reduced in its signal strength in the
Zscan102/2 mutant retina versus that of a heterozygous
littermate, yet this would require further quantitative analysis
(see Figure S6C,I). No change in expression forHes5 was observed
in other organs analyzed. Sox2 was found expressed in the heart,
neural tube and eye similar to, but at much lower levels than
Zscan10, equivalent expression was observed in the apical
ectodermal ridge. No coexpression was detected in the vertebrate
body and for the homozygous mutant in kidney and adrenal (see
Figure S6Y-P9).
Discussion
Zscan10 was originally discovered in screens of human and
mouse ESC to identify genes with relevance in maintaining a
pluripotent state of these cells. The established interaction of
Zscan10 with known pluripotency markers like Oct4 and Sox2 in
ESC suggested a potentially crucial role of Zscan10 in early mouse
development [1]. Oct4 is a homeodomain transcription factor of
the POU family, highly expressed in ESC and with a critical
function in maintaining pluripotency [30]. In its absence an ICM
does not form [31]. Oct4 becomes silenced upon differentiation
with the exception of its requirement for the viability of germ cells
[32]. Ectopic expression of Oct4 from the ROSA26 locus resulted
in dysplasia in the gastrointestinal tract and skin due to an increase
in progenitor cells [33]. Oct4 is capable of heterodimerization with
Sox2, a transcription factor and member of the SRY-related
HMG-box (Sox) family. Heterozygous mutations in the Sox2 gene
have been linked to eye malformations like anophthalmia and
microphthalmia [34,35]. Sox2 is further known to interact with
Pax6, a master control gene during eye development [36,37,38]
with pleiotropic effects in mouse and human when mutated
amongst some are the proliferative control of neural stem or
progenitor cell populations [39] and pancreatic a-cell development
[40]. Notably the pancreas and spleen originate from a shared
embryonic lineage [41].
Zscan10 mutants partially phenocopy Sox2 and Pax6
hypomorphs
We have successfully generated fertile homozygous mutant mice
for Zscan10 using the gene trap clone #285B6 obtained from
CMMR. Our initial phenotype assessment indicated a slight
decrease in the number of homozygous mutant females at weaning
age as well as a size reduction in homozygous mutant mice. A
more detailed phenotype analysis conducted by the GMC
confirmed significantly reduced body weight, a significant
reduction in absolute heart weight, tibia length, and a reduced
bone mineral content was observed in homozygous female
mutants, however ALP activity was not increased in mutant
animals as usually seen in mice with increased bone turnover.
Furthermore a significant reduction in absolute spleen weight in
both genders was noted, while the liver weight was only
significantly increased in homozygous males.
A detailed eye screen conducted by GMC identified a
significant reduction in the eye size and axial eye length in both
genders. There was also a borderline significantly increased
opacification, yet no abnormalities in retinal layers or vascular-
ization of the fundus of homozygous mutants. Overall, this
resulted in reduced vision in the female mutants. Aniridia,
anophthalmia and microphthalmia have been associated with
Figure 2. Hematological and clinical chemistry analysis. (A) Plasma electrolyte, protein, creatinine and urea concentrations of ad libitum fed
mice. (B) Lipid and glucose levels as well as selected enzyme activities in plasma of ad libitum fed mice. (C) Plasma concentrations of minerals, iron
and ALP activity of ad libitum fed mice. (D) Values obtained from EDTA-blood samples. Means, standard deviations and p-values for genotype, sex
and genotype x sex interaction effects calculated by a linear model (A-D). Platelet (E) and mean platelet volume (F) boxplot strip chart, split by sex
and genotype. (G) Concentration of steroid hormones in plasma: Medians, first and third quartile and p-values calculated by a Wilcoxon rank-sum test
(n = 57). Points are individual animals; circles represent females (f); diamonds represent males (m) of Zscan10 homozygous mutants (mut) and wild
type littermates (con). Line within the boxplot represents median. Box represents the 25% and 75% quantile. Asterix represents the mean. Circled
points: Values outside the upper whisker (min(max(x), 75% quantile +1.5*IQR) and outside the lower whisker (max(min(x), 25% quantile+1.5*IQR) =
outliers. IQR = interquartile range (75% quantile–25% quantile).
doi:10.1371/journal.pone.0104568.g002
Figure 3. Open Field Testing. Distance traveled (A), percent distance in the center (B) and percent time spent in the center (C). Total boxplot with
strip chart, split by sex and genotype. Points are individual animals; circles represent females (f); diamonds represent males (m) of Zscan10
homozygous mutants (mut) and wild type littermates (con). Line within the boxplot represents median. Box represents the 25% and 75% quantile.
Asterix represents the mean. Circled points: Values outside the upper whisker (min(max(x), 75% quantile +1.5*IQR) and outside the lower whisker
(max(min(x), 25% quantile+1.5*IQR) = outliers. IQR = interquartile range (75% quantile–25% quantile).
doi:10.1371/journal.pone.0104568.g003
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haploinsufficiency of SOX2 while anterior eye defects, including
defects of the iris and ciliary body have been associated with
haploinsufficiency of PAX6 in humans [34,37,42,43,44,45,46,47].
Analysis of eye development in Sox2 hypomorphic mice indicated
variable degrees of microphthalmia attributed to abnormal neural
progenitor proliferation, consistent with findings in human [48]. A
Figure 4. Small eye phenotype in Zscan10 homozygous mutant mice. Lateral (A) and frontal (B) view of adult mutant (left) and wild type
(right) mice. Lateral view of right eye of a wild type (C) and mutant (D) adult female. (E) Eye size measurements by laser interference biometry
revealed significantly reduced axial eye length in mutants of both sexes (p,0.001). Anterior eye investigation by Scheimpflug imaging indicated
significantly increased mean lens density between controls and mutants for left eyes in males (p = 0.002) (F) and right eyes in females (p = 0.016) (G).
Virtual drum vision testing showed a reduced response with borderline significance in female mutants (p = 0.034) (H). (E) to (H) are displayed as
boxplot split by sex and genotype. Outliers are indicated by open circles.
doi:10.1371/journal.pone.0104568.g004
Figure 5. Organ weight determined in pathology screen. (A) Normalized liver weight is significantly increased in male mutant mice (P = 0.008).
(B) Absolute spleen weight is significantly reduced in mutant mice of both genders. (C) Normalized spleen weight is significantly reduced in female
mutant mice (P = 0.002). (D) Absolute heart weight is significantly reduced in female mutant mice (p = 0.003). (E) Normalized heart weight is
significantly reduced in female mutant mice (p = 0.016). All results demonstrated as boxplot with strip chart, split by sex and genotype. For tibia
length refer to Figure 1F. Points are individual animals; circles represent females (f); diamonds represent males (m) of Zscan10 homozygous mutants
(mut) and wild type littermates (con). Line within the boxplot represents median. Box represents the 25% and 75% quantile. Asterix represents the
mean. Circled points: Values outside the upper whisker (min(max(x), 75% quantile +1.5*IQR) and outside the lower whisker (max(min(x), 25%
quantile+1.5*IQR) = outliers. IQR = interquartile range (75% quantile–25% quantile).
doi:10.1371/journal.pone.0104568.g005
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Figure 6. Punctuated Zscan10 expression in E12.5 wild type embryos as determined by SISH. Sagittal sections through E12.5 wild type
embryos for reference as Mallory tetrachrome staining (A), with T7 antisense probe (B) and T3 sense probe (C). T7 antisense probe on transverse
sections reflecting Zscan10 expression in the lining of the stomach (D), kidney and lining of the gut (E) at 4x; on sagittal sections through the eye (F),
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follow up study with conditional Sox2 mutant mice revealed an
inversely correlated gradient between Sox2 and Pax6 expression
in the developing optic cup and demonstrated the importance of
the functional antagonism between Sox2 and Pax6 during
patterning of the eye cup [49]. Hes5 is a known downstream
effector in the Notch pathway, important in the cell fate decision of
retinal progenitor cell populations [29]. We observed a slightly
reduced expression of Hes5 in Zscan10 mutant retinas. The
previously demonstrated physical in vitro interaction between
Zscan10 and Sox2 [1], the coexpression of Zscan10 and Sox2
demonstrated here in the eye and the small eye phenotype
identified during the GMC phenotyping screen nominates
Zscan10 as a new player in the concerted interaction of
transcription factors during eye development.
Altered platelet counts and an activated immune status
in Zscan10 homozygous mutants
The finding, that a slightly decreased platelet count is associated
with an increase mean platelet volume (MPV) in Zscan10 mutant
mice compared to controls, fits to the observation that these
parameters are usually negatively correlated [50,51]. Increased
MPV values and the occurrence of ‘‘large platelets’’ can indicate
changes in cytoskeletal structures or an increased proportion of
pre-platelets and pro-platelets (prePLT, proPLT) as well as young
platelets, which can occur in response to thrombopenia [51].
Increased platelet size goes together with higher platelet reactivity
and is associated with diabetes mellitus and an increased risk of
cardiovascular diseases in humans and is therefore considered as
an important diagnostic marker [50,52,53]. A recent GWAS study
identified 68 loci associated with platelet number and volume [54].
The slightly decreased platelet count in homozygous Zscan10
mutants associated with increased MPV values could therefore
result from changes in number and function of megakaryocytes –
which could be in line with the suggested role of Zscan10 in
maintaining sufficient numbers of progenitor cells - resulting in
effects on cell differentiation, platelet formation or platelet
maturation. A decrease in the number of megakaryocytes could
be compensated by an increased activity of these cells leading to
the observed differences, as it was described for the response to
pharmacologically induced thrombopenia [50,51]. On the other
hand these changes could occur due to changes in cytoskeletal
structure or secondarily to an increased platelet consumption or
destruction. Further investigations are necessary to elucidate the
underlying cause.
Zscan10 homozygous mutant mice display behavioral
alterations
The Open Field Test was originally described to study
emotionality in rats [55] with emotional rats executing fewer
entries in the central part of the test arena and higher levels of
defecation. Glucocorticoid hormone levels can be indicative of
stress tolerance with corticosterone levels being elevated during
periods of stress [56,57]. The acoustic startle response and PPI
measure auditory sensorimotor integration and an increased
acoustic startle response can be indicative of increased anxiety
levels. Impaired PPI has been associated with human disorders
lower abdomen (G), heart (H), humerus (I) and vertebral body (K), as well as transverse sections through the neural tube (J) at 10x. All pictures were
taken on a Motic compound microscope with a Motic Moticam 2.0MP digital camera. Brain (br), liver (li), dorsal root ganglia (drg), stomach (sto),
kidney (ki), gut (gt), lens (le), retina (re), heart (he), bone (bn), neutral tube (nt), notochord (nc) and vertebral body (vb).
doi:10.1371/journal.pone.0104568.g006
Figure 7. Punctuated Zscan10 expression persists in adult tissue. SISH on sections through heart (A,D), kidney (B,E) and eye (C,F) probed with
the T7 Zscan10 antisense probe taken at 0.636 (A,B) and 2.56 (C) on a Leica S6 dissecting scope and magnifications thereof (D,E,F) taken on a Motic
compound microscope at 106 all documented with a Motic Moticam 2.0MP digital camera.
doi:10.1371/journal.pone.0104568.g007
Zscan10 Pleiotropic Functions
PLOS ONE | www.plosone.org 11 August 2014 | Volume 9 | Issue 8 | e104568
such as: schizophrenia, Huntington’s disease, fragile X syndrome
and autism and involves amongst other signaling centers the limbic
cortex [58,59]. The GMC steroid screen at 16 weeks of age
indicated decreased corticosterone levels in plasma of Zscan10
homozygous male mutant mice, and a trend in the opposite
direction in female mutants. Significantly increased urination was
observed in Zscan10 mutants, female Zscan10 mutants were
slightly more active in the OFT, including more entries into and
more distance travelled in the ‘‘anxiogenic’’ center zone of the
OFT. It could be hypothesized based on the expression of
Zscan10 in the embryonic brain that an impact on a pluripotent
progenitor cell population for example in the limbic system could
influence anxiety related behavior along the way of observations
made in Dlx1 loss-of function mutants [60], where the Dlx1 sense
[60,61,62,63] and antisense transcript level is critical in progenitor
fate decisions [15]. However, female Zscan10 homozygous
mutants also show an increased acoustic startle response, which
is not consistent with the notion of reduced anxiety, and
demonstrated a functional visual impairment in the optokinetic
drum test. It cannot be excluded that this visual impairment might
have played a role in the observed OFT behavior of female
Zscan10 homozygous mutants, since it could affect the perception
of the arena and its center zone as anxiogenic. The increased
urination observed in the neurology screen could however also be
due to a renal dysfunction as indicated by the results from the
clinical chemistry screen which revealed increased urea and
creatinine levels as well was a slight hypocalcemia in males that
among other causes can also be attributed to renal dysfunction.
Taken together, further neurological examinations and immu-
nohistochemistry would be required to identify the exact nature of
Zscan10 homozygous mutant behavior.
Zscan10 remains expressed in potential progenitor cells
of diverse organs
All phenotypic findings were coherent with the embryonic and
adult Zcan10 gene expression patterns established by SISH.
Previous WISH expression patterns in midgestation embryos
could have misinterpreted the punctate expression pattern of
Zscan10 as background staining. We propose based on a more
refined expression pattern by SISH, the known interaction
partners of Zscan10 [1] and the pleiotropic phenotype observed
in Zscan10 mutants, that Zscan10 could play a role in regulating
the availability of progenitor cells during mouse embryonic
development and adulthood. In the case of Zscan10 hypomorphic
or loss-of-function mutations the number of progenitors might be
reduced, either by a decrease in progenitor cell division or by
premature terminal differentiation causing an overall reduction in
cell mass of a variety of target tissues namely eye, heart, long bones
and spleen. Identified grip strength, immunological and blood
chemistry abnormalities could be downstream effects of the impact
on progenitor cell populations in the affected organs. The
pluripotency marker Sox2 is coexpressed in many but not all of
these organs, yet generally in fewer cells compared to Zscan10.
This is not surprising as progenitor cells might have acquired a
certain maturity and as such are no longer of pluripotent nature,
yet can act as multipotent progenitors for cells at an advanced
differentiation level. The exact mechanism by which Zscan10 acts
in a given progenitor cell population in vivo remains to be
determined.
In summary, the observed eye phenotype in homozygous
Zscan10 mutant mice supports previously proposed in vivo
interactions between Sox2 and Zscan10 based on earlier in vitro
assays. The nature of the cellular expression pattern of Zscan10 in
midgestation embryos and adult organs and the changes in
absolute weight of several organs as well as the composition of
several cell populations in the homozygous mutants suggests a role
for Zscan10 in maintaining a multipotent progenitor cell
population or impacting on fate choice decisions thereof.
Supporting Information
Figure S1 Gene trap strategy. Illustrated is the pUPA-TRAP
vector (not drawn to scale) as used by CMMR that was integrated
into intron 1 upstream of the ATG start codon. Exons of the
currently known five Zscan10 transcripts are drawn to scale as
rectangular boxes, yellow and white representing coding and
untranslated regions, respectively. The 270 bp SISH probe (purple
lines) is covering most of exon 3, all of exon 4 and part of exon 5
and is drawn to scale for transcript 1. Transcripts after insertion of
the pUPA-TRAP vector before and after Cre-recombination are
indicated. Generation of Zscan10 protein after Cre-recombination
is highly unlikely based on the design of the pUPA-TRAP vector.
Transcription start site (TSS, black bend arrow), translation start
(green arrow heads), translation stop (red arrow heads), splice
acceptor site (SA), internal ribosome entry site (IRES), polyade-
nylation site (pA), RNA polymerase II promoter (RNAPII),
recognition site for Cre recombinase (loxP), splice donor site
(SD). Integration site of pUPA-TRAP vector is indicated by the
blue arrow.
(EPS)
Figure S2 Results of the immunological screen. (A)
Frequencies of leukocyte subpopulations during flow cytometry
in peripheral blood after erythrocyte lysis [percentage of all
leukocytes (CD45+ cells), or corresponding parent gate, respec-
tively]. Means, standard deviation and p-values calculated by a
linear model. (B) Levels of immunoglobulins (ug/ml) in blood
plasma. Medians, first and third quartile and p-values calculated
by Wilcoxon rank-sum test. Missing measurements caused by Ig
levels above and below measurability were replaced by 0.9*min/
1.1*max of respective Ig measurement (n = 57). (C) Total IgE in
plasma were in normal range. Medians, first and third quartile and
p-values calculated by a Wilcoxon rank-sum test.
(TIF)
Figure S3 Open Field Testing. Means, standard deviation
and p-values calculated by a linear model (n = 60).
(TIF)
Figure S4 Organ weight.Medians, first and third quartile and
p-values calculated by a Wilcoxon rank-sum test (n = 57).
(TIF)
Figure S5 Western blot of the homozygous Zscan10
mutant (2/2) ESC line L2 in comparison to wild type
(+/+) and heterozygous (+/2) ESC. Using 15 ug each with
the GIS206-Ab [1], maintained on mouse embryonic fibroblasts
(MEF) or on MEF-free gelatinized plates (GEL) and aRB-HRP as
loading control.
(EPS)
Figure S6 Sox2, Hes5 and EGFP expression in compar-
ison to Zscan10. Sections through E15.5 (A-X) and E12.5 (Y-P9)
Zscan102/2 (G-R, K9-P9) and Zscan10+/2 (A-F, S-J9) mouse
embryos showing expression of the transcription factors Hes5 (A-
L), Zscan10 (S-D9) and Sox2 (E9-P9) as well as the pUPA reporter
EGFP (M-R). Organs expressing the Notch pathway effector Hes5
did not show any obvious difference in Hes5 expression between
Zscan102/2 and Zscan10+/2 embryos as shown for the brain
(A,G) neural tube (nt) (B,H) gut (D,J) and liver (E,K) with
exception of the retinal layer (C,I), where theHes5 signal appeared
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less intense, either due to reduced expression levels or fewer cells
expressingHes5 in the Zscan102/2 eye (I). Ectopic upregulation of
Hes5 in chondrogenic tissue was not observed (F,L). EGFP
expression was similar to Zscan10 expression in all organs assayed
for namely: Adrenal (M,S), kidney (N,T), heart (O,U), lung (P,V)
vertebrae body and forming intervertebral disc (Q,W) and dorsal
root ganglia (drg) (R,X). Sox2 was not detected in kidney and
adrenal (E9,K9), only faintly expressed in nt and drg (G9,M9) but
found coexpressed with Zscan10 in the heart (Z,F9,L9), the apical
ectodermal ridge (aer) (C9,I9,O9) and the retina (D9,J9,P9).
(TIF)
Table S1 Genotyping results from offspring at weaning
age (n=153). P-value is calculated as one tailed probability
values with n= 2 degrees of freedom.
(EPS)
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